|
Company Report
|
 Pharma is divesting in order to grow
Pharmaceutical companies are now divesting non-core assets such as medical devices and manufacturing plants in an effort to cut costs and focus on core strategies, primarily drug development. However, while some Pharma companies are narrowing their focus, targeting specific disease areas for future growth, others are taking a broader approach in an effort to spread risk and return on investment.
|
|
Read more...
|
|
|
Company Report
|
The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses
The global generics market grew at a faster pace than the global pharma market in 2007, with a CAGR of 16.4% during 2004–2007. Regular patent expirations of blockbuster drugs are the primary growth driver of the industry. Rising healthcare expenditure has also contributed to industry expansion, with governments coming under growing pressure to provide low cost alternatives to branded drugs.
|
|
Read more...
|
|
|
Company Report
|
PharmaVitae: Company Comparator Tool
The Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales to 2012.
|
|
Read more...
|
|
|
Company Report
|
Bayer Schering Pharma AG: PharmaVitae Profile
This analysis examines the historical and forecast performance for Bayer Schering Pharma in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
|
|
Read more...
|
|
|
Company Report
|
Wyeth: PharmaVitae Profile
This analysis examines the historical and forecast performance for Wyeth in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
|
|
Read more...
|
|
|
Company Report
|
Johnson & Johnson: PharmaVitae Profile
This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
|
|
Read more...
|
|
|
Company Report
|
AstraZeneca plc: PharmaVitae Profile
This analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
|
|
Read more...
|
|
|
Company Report
|
Schering-Plough Corporation: PharmaVitae Profile
This analysis examines the historical and forecast performance for Schering-Plough in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
|
|
Read more...
|
|
|
Company Report
|
Amgen Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Amgen in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
|
|
Read more...
|
|
|
<< Start < Prev 21 22 23 24 25 26 27 28 29 30 Next > End >>
|
| Results 262 - 270 of 324 |
Farmavita.Net Journal 
